LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.85 Cr | ₹2.24 Cr | ₹5.91 Cr | ₹7.82 Cr | ₹-3.17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LASA SUPERGENERICS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2024 | ₹4.85 Cr |
| Mar2023 | ₹2.24 Cr |
| Mar2022 | ₹5.91 Cr |
| Mar2021 | ₹7.82 Cr |
| Mar2020 | ₹-3.17 Cr |
How is Deferred Tax Assets / Liabilities of LASA SUPERGENERICS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹4.85 Cr | 116.91 | |
| Mar2023 | ₹2.24 Cr | -62.20 | |
| Mar2022 | ₹5.91 Cr | -24.42 | |
| Mar2021 | ₹7.82 Cr | Positive | |
| Mar2020 | ₹-3.17 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹31.3 Cr | -3.1% | -22.7% | -67.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -3.1% |
-22.7% |
-67.8% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses